Bio City Campus
Business and Science United.

Welcome to BioCity Campus Leipzig!

We are pleased to welcome you to the BioCity Campus website. Take a look around and discover new possibilities in the fields of biotechnology, life sciences and healthcare on the Old Trade Fairgrounds in Leipzig in the heart of Germany. Enjoy getting to know us on the following pages.

Develop your visions

With the relocation of the Leipziger Messe (Leipzig Trade Fair) to the north of the city, new opportunities for science and research arose in the southeastern part of Leipzig. Thus the Old Trade Fair (“Alte Messe Leipzig”), with its centuries of history, now offers generous spaces and exhibition hall areas for diverse uses and almost every kind of commercial activity.

On the basis of these different realities, the BioCity Campus project was initiated based on these diverse opportunities, which was dedicated primarily to the implementation of the following goals:

  • Usage of the unique developmental dynamic of the biotech-oriented life sciences fields that have located themselves at the Old Trade Fairgrounds.
  • Development of a typically urban building ensemble that provides, as a “technology campus”, a high level of identification for those already established there, while also increasing the national recognition factor.
  • Inclusion of the urban-public sphere in the technological development of the life sciences sector; young people in particular should be drawn to the natural and engineering sciences.
  • Designing innovative use and development concepts and putting them to the test.
  • Development of new, unconventional collaboration structures between politics, science and civil society in the context of urban development.

André Hofmann, CEO BIO-NET LEIPZIG, talks about BioCity Campus and BIO CITY LEIPZIG


We know all about the importance of a strong network. Here at the BIO CITY Campus, you benefit from partners who will welcome you with open arms.


The BioCity Campus is the biotechnology and life sciences park located on the historic grounds of the Old Trade Fair (“Alte Messe Leipzig”) close to the city center. The area hosts a biotechnology and biomedical cluster capable of incorporating the benefits of neighboring research facilities that will continue to support resident businesses through a targeted extension of the value-creation chain.


We can offer you fully-developed and individually customized plots of land with excellent infrastructure connections.


150,000 stem cell deposits at Vita 34

Vita 34 on the BioCity Campus Leipzig celebrates the 150000th stem cell storage and the 20th company anniversary with an international expert symposium on the application of stem cells in children. With 150,000 stem cell deposits from 29 countries in Europe and worldwide as well as 30 applications, Vita 34 is the largest and most experienced stem cell bank in the German-speaking countries.

c-LEcta Extended its Biodiversity Platform by Genomic Libraries from Marine Sources

To meet the demand of new enzymes for industrial applications c-LEcta has extended its biodiversity platform by Genomic libraries from marine sources. New and innovative process technologies in industry demand highly advanced enzymes that can cope with harsh reaction conditions while simultaneously offering highest performance. The analysis of natural biodiversity provides a practically unlimited source for identification of such new enzymatic activities as well as bioactive compounds.

iDiv: Carnivores more seriously threatened by roads than previously acknowledged

The effects of roads on carnivores have obviously been underestimated in worldwide species conservation. This is the conclusion of the first comprehensive global study on this topic, which has been published in the scientific journal “Global Ecology and Biogeography” by an international research team from Germany and Portugal. The protection status of several species that are severely affected by roads cut through their habitat should be reconsidered, the researchers say.

Fraunhofer IZI and Immunic GmbH carry out joint research on new drugs for treating autoimmune diseases

Fraunhofer IZI. Since January 2017, researchers from Immunic GmbH have been working with scientists at the Department of Drug Design and Target Validation of the Fraunhofer IZI in Halle (Saale) on developing new drugs. The aim is the preclinical development of one or several active candidate ingredients for treating chronically inflammatory and autoimmune diseases.